ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchas…
Author: Business Wire
National Vision Appoints Caitlin Zulla to Board of Directors
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced today the appointment of Caitlin Zulla to its Board of Directors, ef…
Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”) announced today the appointment of Ron Williams as Lead Director. “Ron’s deep expertise in transformational leadership is helping Warby Parker lead the way in m…
LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that the Company’s second quarter 2024 fina…
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an in…
New ZEISS Study Finds Majority of Parents Worry About Impact of Screen Time on Their Children’s Eye Health, Value Protective Behaviors to Maintain Eyesight
HEBRON, Ky.–(BUSINESS WIRE)–Amid Children’s Eye Health and Safety Month, ZEISS Recommends New SmartLife Young Lenses Designed to Meet Changing Needs of Children and Teenagers
Glaukos Announces Second Quarter 2024 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
Bausch + Lomb Announces Second-Quarter 2024 Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2024 financial results. “Our continued growth i…
STAAR Surgical to Report Second Quarter Results on August 7, 2024
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it wil…
Weave Now Integrates with eClinicalWorks
LEHI, Utah–(BUSINESS WIRE)–Weave (NYSE: WEAV), a leading all-in-one experience platform for small and medium-sized healthcare businesses, today announced an integration with eClinicalWorks, the largest cloud-based EHR software in the U.S., offering s…
Bifrost Biosystems Appoints Industry Veteran Jonas Jarvius, PhD as CEO
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Bifrost Biosystems, a pioneer in Optical Pooled Screening (OPS) technologies, today announced the appointment of experienced life sciences industry executive, Jonas Jarvius, PhD, as Chief Executive Officer, President …
Collective Health Welcomes Halle Tecco to its Board of Directors
SAN FRANCISCO–(BUSINESS WIRE)–Collective Health today announced the addition of digital health entrepreneur, investor, and industry luminary Halle Tecco to its board of directors. Tecco is a pioneering force in the healthcare industry, known for her …
Synchron Announces First Use of Apple Vision Pro with a Brain Computer Interface
NEW YORK–(BUSINESS WIRE)– #Apple–Synchron Announces First Use of Apple Vision Pro with a Brain Computer Interface
STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the g…
NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova®-branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales…
Merck Announces Second-Quarter 2024 Financial Results
RAHWAY, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Merck Announces Second-Quarter 2024 Financial Results
Resumen: Novaliq recibe la opinión positiva del CHMP para Vevizye® en el tratamiento del ojo seco
HEIDELBERG, Alemania y CAMBRIDGE, Massachusetts–(BUSINESS WIRE)–Novaliq, una empresa biofarmacéutica centrada en terapias oculares de primera y mejor calidad basadas en la exclusiva tecnología EyeSol® sin agua, anuncia que el Comité de Medicamentos d…
Samenvatting: Novaliq ontvangt positief CHMP-advies voor Vevizye® bij droge ogen ziekte
HEIDELBERG, Duitsland & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Novaliq, een biofarmaceutisch bedrijf dat zich richt op eersteklas en best-in-class oculaire therapieën op basis van de unieke watervrije EyeSol®-technologie, kondigt aan dat het Comité voor ge…
Riassunto: Novaliq riceve un'opinione positiva dal CHMP per Vevizye® nella sindrome dell'occhio secco
HEIDELBERG, Germania e CAMBRIDGE, Mass.–(BUSINESS WIRE)–Novaliq, una società biofarmaceutica incentrata su terapie oculari di prima e migliore qualità a base dell’esclusiva tecnologia senz’acqua EyeSol®, annuncia che il Comitato per i Medicinali per …
Novaliq的Vevizye®干眼病药物获得CHMP积极意见
德国海德堡和马萨诸塞州剑桥–(BUSINESS WIRE)–(美国商业资讯)– 专注于基于独特EyeSol®无水技术率先开发一流眼科治疗药物的生物制药公司Novaliq宣布，欧洲药品管理局人用药品委员会(CHMP)已通过积极意见，建议在欧盟授予Vevizye®的上市许可。该药用于治疗中度至重度干眼症的成年患者，这些患者在使用泪液替代品治疗后仍未见改善。 干眼症(DED)是最常见的眼表疾病之一，在欧洲五大国家约有1500万确诊患者1，而且难以治疗2。在欧洲，干眼症的治疗选择有限，只有一种获批的药…